Quick Answer
NeuroPace Inc reported Net Income Loss of -$21.47 million for the year ending 2025.
- NeuroPace Inc showed an increase of +20.9% in Net Income Loss from 2024 to 2025.
- This data is from NeuroPace Inc's annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: -$6.74 million | Q2 2020: -$8.79 million | Q3 2020: -$4.13 million | Q1 2021: -$8.81 million | Q2 2021: -$8.49 million | Q3 2021: -$8.08 million | Q1 2022: -$11.46 million | Q2 2022: -$12.69 million | Q3 2022: -$11.79 million | Q1 2023: -$10.38 million | Q2 2023: -$9.12 million | Q3 2023: -$7.26 million | Q1 2024: -$8.93 million | Q2 2024: -$7.51 million | Q3 2024: -$5.45 million | Q1 2025: -$6.59 million | Q2 2025: -$8.65 million | Q3 2025: -$3.50 million.
- Over the full 6 years of available data (2020 to 2025), NeuroPace Inc's Net Income Loss has grown by 11.6%.
- Historical annual values: Fiscal year 2025: -$21.47 million | Fiscal year 2024: -$27.14 million | Fiscal year 2023: -$32.96 million | Fiscal year 2022: -$47.08 million | Fiscal year 2021: -$36.08 million | Fiscal year 2020: -$24.28 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: